TY  - GEN
AU  - Tap,William D
AU  - Demetri,George
AU  - Barnette,Phillip
AU  - Desai,Jayesh
AU  - Kavan,Petr
AU  - Tozer,Richard
AU  - Benedetto,Pasquale W
AU  - Friberg,Gregory
AU  - Deng,Hongjie
AU  - McCaffery,Ian
AU  - Leitch,Ian
AU  - Badola,Sunita
AU  - Chang,Sung
AU  - Zhu,Min
AU  - Tolcher,Anthony
TI  - Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors
SN  - 1527-7755
PY  - 2012///0723
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Bone Neoplasms
KW  - blood
KW  - Desmoplastic Small Round Cell Tumor
KW  - Female
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Insulin-Like Growth Factor I
KW  - metabolism
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Oncogene Proteins, Fusion
KW  - genetics
KW  - Proto-Oncogene Protein c-fli-1
KW  - RNA-Binding Protein EWS
KW  - Receptor, IGF Type 1
KW  - antagonists & inhibitors
KW  - Sarcoma, Ewing
KW  - Sequence Analysis, RNA
KW  - Time Factors
KW  - Translocation, Genetic
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2011.37.2359
ER  -